2 Approved! With Just One Oral Dose Per Day, This Type Of Breast Cancer Patient Gets a New Drug Dec 13, 2024
4 Heavyweight! First ADC Drug For Refractory Ovarian Cancer Receives Accelerated FDA Approval Dec 01, 2024
6 K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients! Nov 28, 2024
Read More Apparatus Clinical Approval For Colombotide Skb264 (Mk-2870) In Combination With Oxitinib Dec 04, 2024
Read More Medical Cutting-edge 'peptide' shows promise in stopping breast cancer metastasis! Dec 02, 2024
Read More Medical Neoadjuvant Chemotherapy Reduces Colon Cancer Recurrence Rate By 28%, With Fewer Post-Operative Complications, Study Shows Dec 07, 2024
